GlassScriptPhysician profile
Danielle Morgan
NPI 1780974691
$596.97
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $46.86 · 2021: $60.38 · 2022: $113 · 2023: $102 · 2024: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $133.29 | 2019-2022 | |
| Penumbra, INC. | $119.47 | 2024 | Indigo System |
| Corium, LLC | $109.61 | 2023-2024 | Azstarys |
| Kaleo, INC. | $71.33 | 2021-2023 | Auvi-Q |
| Neurelis, INC. | $52.82 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $52.46 | 2020-2023 | M-M-R II, Gardasil 9, Vaxelis |
| Seqirus USA INC | $28.79 | 2022-2023 | Flucelvax Quadrivalent |
| Medline Industries LP | $17.07 | 2022 | |
| Glaxosmithkline, LLC. | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.